Dr Rebecca Kristeleit
HCA Healthcare UK at University College Hospital, 5th Floor, Macmillan Cancer Centre, Huntley Street, London WC1E 6AG; Wellington Hospital (Platinum Medical Centre, 15-17 Lodge Road, NW8 8NX); The Royal Free Hospital, Pond Street, London, NW3 2QG
Experimental therapeutics – Phase I first-in-man and Phase II/III in gynae malignancies
Rebecca was appointed Clinical Senior Lecturer and Consultant Medical Oncologist at UCL/UCLH in 2009. She has a specialist interest in drug development as well as the treatment of gynaecological malignancies. She is leading several clinical trials of novel agents relevant to gynaecological malignancies including PARP inhibitors.
Rebecca qualified in medicine from St Andrew’s and Manchester Universities including eight months at the University of Lausanne (Switzerland) on an Erasmus scholarship. Following general medical training in London, she undertook her medical oncology training at the Royal Marsden Hospital and a CRUK-funded research fellowship at the Institute of Cancer Research. Subsequently, Rebecca spent a year as a senior research fellow on the Drug Development Unit at the Royal Marsden Hospital gaining specialist experience in the design and conduct of early phase clinical trials and translational medicine.
Her research work, as part of the UCLH gynaecological oncology team, Clinical Research Facility at UCLH and the UCL Cancer Institute, is focused on the development of early phase clinical trials and translational research to identify and evaluate innovative treatment strategies for gynaecologic malignancies as well as other solid tumours.
Rebecca is a member of the NCRI endometrial cancer subgroup. She has received grant funding from CRUK and ECMC. She teaches undergraduate and postgraduate UCL students and supervises students undertaking higher research degrees.